Trial Information

Summary: A study of the use of donepezil hydrochloride (Aricept ) in 10 to 17 year olds with Down Syndrome (Trisomy 21)

A study of the use of donepezil hydrochloride (Aricept ) in 10 to 17 year olds with Down Syndrome (Trisomy 21)

• Trisomy 21 Down Syndrome, mild to moderate congnitive dysfunction
• Between the ages of 10 and 17
• Residing in the community with a caregiver
• Have no unstable health conditions
• Be able to submit to blood tests
• The child should be verbal
• On stable doses of medications

Contact: Roseanna Zamora Rocky Mountain Pediatrics, PC 2020 Wadsworth Blvd, Ste 16 Lakewood, CO 80232 Telephone: 303-233-8701 Fax: 303-233-2820

Maps by Google



This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:44:19 AM